1. | ltxguy6100 | |
2. | kkappel7947 | |
3. | bigbooter16 | |
4. | jasonbennett387 | |
5. | drsillinois |
1. | ltxguy6100 | |
2. | kkappel7947 | |
3. | bigbooter16 | |
4. | jasonbennett387 | |
5. | drsillinois |
1. | kkappel7947 02/12/2018 FDA accepted and granted Priority Review |
2. | kkappel7947 01/25/2018 Johnson & Johnson has pulled out of the race to buy Pfizer's consumer health business, leaving GlaxoSmithKli… |
3. | bigbooter16 04/05/2018 Barclays cuts price target to $38 from $41 |
4. | ltxguy6100 01/29/2018 SunTrust Robinson Humphrey raises price target to $40 from $33 |
5. | kkappel7947 01/30/2018 Sees FY18 $2.90-3.00 vs $2.78 |
6. | ltxguy6100 03/19/2018 BioDuro Collaboration with Pfizer Inc. Leads to Creation of a Shelf-Stable Fluorosulfation Reagent |
7. | kkappel7947 01/30/2018 Berenberg sets PT at $36 |
8. | ltxguy6100 01/26/2018 good luck |
9. | ltxguy6100 01/26/2018 European regulators approved Pfizer and Merck's diabetes drug Steglatro |
10. | kkappel7947 01/24/2018 Wow News??? - BMO Capital sets PT at $39... a whole $2 |